Screening for kidney diseases: Older measures versus novel biomarkers

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 6, 2008, Pages 1895-1901

  Wu, Ian ^a   Parikh, Chirag R ^a,b  

^a YALE UNIVERSITY   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE;

BLOOD; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LIVER CIRRHOSIS; MASS SCREENING; METABOLISM; METHODOLOGY; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW;

BIOLOGICAL MARKERS; CREATININE; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LIVER CIRRHOSIS; MASS SCREENING; NEPHROTIC SYNDROME; POLYCYSTIC KIDNEY DISEASES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 58149357175     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02030408     Document Type: Review

References (61)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
2. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002
3. Ostermann M, Chang RW: Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 35: 1837-1843; quiz 1852, 2007
4. Tseng CL, Kern EF, Miller DR, Tiwari A, Maney M, Rajan M, Pogach L: Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 168: 55-62, 2008
5. Gwinner W, Hinzmann K, Erdbruegger U, Scheffner I, Broecker V, Vaske B, Kreipe H, Haller H, Schwarz A, Mengel M: Acute tubular injury in protocol biopsies of renal grafts: Prevalence, associated factors and effect on long-term function. Am J Transplant 8: 1684-1693, 2008
6. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70: 199-203, 2006
7. Bellomo R, Kellum JA, Ronco C: Defining acute renal failure: Physiological principles. Intensive Care Med 30: 33-37, 2004
8. Coca SG, Yalavarthy R, Concato J, Parikh CR: Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 73: 1008-1016, 2008
9. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003
10. Bachorzewska-Gajewska H, Malyszko J, Sitniewska. E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S: Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res 30: 408-415, 2007
11. Dent CL, Ma Q, Dastrala. S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P: Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study. Crit Care 11: R127, 2007
12. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148: 810-819, 2008
13. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107: 1145-1152, 2001
14. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 43: 405-414, 2004
15. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16: 3046-3052, 2005
16. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237-244, 2002
17. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ: High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 84: 1625-1630, 2007
18. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36: 29-34, 2000
19. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 66: 1115-1122, 2004
20. Herget-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A: Cystatin C: Efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 20: 97-102, 2000
21. Betrosian AP, Agarwal B, Douzinas EE: Acute renal dysfunction in liver diseases. World J Gastroenterol 13: 5552-5559, 2007
22. Newell GC: Cirrhotic glomerulonephritis: Incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 9: 183-190, 1987
23. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V: Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56: 1310-1318, 2007
24. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB: Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transpl 10: 301-309, 2004
25. Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA: Octreotide/ Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci 52: 742-748, 2007
26. Demirtas S, Bozbas A, Akbay A, Yavuz Y, Karaca L: Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 311: 81-89, 2001
27. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, Padrini R, Palatini P: Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48:850-858, 2002
28. Bachmann-Brandt S, Bittner I, Neuhaus P, Frei U, Schindler R: Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation. Transpl Int 13: 357-362, 2000
29. Branten AJ, Vervoort G, Wetzels JF: Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant 20: 707-711, 2005
30. Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G: A modern approach to selectivity of proteinuria and tubulo-interstitial damage in nephrotic syndrome. Kidney Int 58: 1732-1741, 2000
31. D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage. Am J Kidney Dis 26: 124-132, 1995
32. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G: Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 17: 1890-1896, 2002
33. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int 66: 1596-1605, 2004
34. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430-1432, 1982
35. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet 349: 1787-1792, 1997
36. Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J, Diabetics Exposed to Telmisartan and Enalapril Study Group: Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 351: 1952-1961, 2004
37. Standards of medical care in diabetes-2007. Diabetes Care 30[Suppl 1]: S4-S41, 2007
38. Valmadrid CT, Klein R, Moss SE, Klein BE: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160: 1093-1100, 2000
39. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, Knowler WC, Monroy M, Libermann TA, Karumanchi SA, Thadhani R: Prediction of diabetic nephropathy using urmie proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 30: 638-643, 2007
40. Pei Y: Diagnostic approach in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 1: 1108-1114, 2006
41. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP, CRISP Investigators: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
42. Serra AL, Kistler AD, Poster D, Struker M, Wuthrich RP, Weishaupt D, Tschirch F: Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study. BMC Nephrol 8: 13, 2007
43. Wallace DP, Hou YP, Huang ZL, Nivens E, Savinkova L, Yamaguchi T, Bilgen M: Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging. Kidney Int 73: 778-781, 2008
44. Coca SG, Parikh CR: Urinary biomarkers for acute kidney injury: Perspectives on translation. Clin J Am Soc Nephrol 3: 481-490, 2008
45. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061, 2001
46. Parikh CR, Garg AX: Acute kidney injury: Better biomarkers and beyond. Kidney Int 73: 801-803, 2008
47. Rehberg PB: Studies on kidney function: The rate of filtration and reabsorption in the human kidney. Biochem J 20: 447-460, 1926
48. Liangos O, Perianayagam. MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Paereira BJ, Bonventre JV, Jaber BL: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18: 904-912, 2007
49. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL: Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care 11: R84, 2007
50. Herrero-Morin JD, Malaga S, Fernandez N, Rey C, Dieguez MA, Solis G, Concha A, Medina A: Cystatin C and beta2-microglobulin: Markers of glomerular filtration in critically ill children. Crit Care 11: R59, 2007
51. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L: Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 21: 1855-1862, 2006
52. Butler EA, Flynn FV: The occurrence of post-gamma protein in urine: A new protein abnormality. J Clin Pathol 14: 172-178, 1961
53. Fossum K, Whitaker JR: Ficin and papain inhibitor from chicken egg white. Arch Biochem Biophys 125: 367-375, 1968
54. Okamura. H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torkqoe K, Okura T, Nukada Y, Hattori K: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91, 1995
55. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425-10432, 1993
56. Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H: Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218: 499-503, 1985
57. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005
58. Hayman JM, Halsted JA, Seyler LE: A comparison of the creatinine and urea clearance tests of kidney function. J Clin Invest 12: 861-875, 1933
59. Miller BF, Winkler AW: The renal excretion of endogenous creatinine in man. Comparison with exogenous creatinine and inulin. J Clin Invest 17: 31-40, 1938
60. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
61. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999